scholarly journals Chłodno i rzeczowo. Kazimierz Sarnecki o chorobach na dworze Jana III Sobieskiego

2021 ◽  
Vol 16 (11) ◽  
pp. 214-226
Author(s):  
Tomasz Ślęczka ◽  

This article addresses the question of illness, as discussed in the writings of Kazimierz Sarnecki, an envoy of Lithuanian Chancellor Karol Stanisław Radziwiłł, residing at King Jan III Sobieski’s court. Sarnecki’s primary task was to take note of all happenings at King Sobieski’s court, focusing mainly on the king’s health, but including also other matters, some of them of little importance. Sarnecki regularly kept Radziwiłł up-to-date through diary entries sent together with a separate cover letter, usually of considerable length. In his diary, Sarnecki detailed the King’s state of health, starting each entry with a short description of what the King was doing and how he felt and only then proceeding to report on other events. Subsequently, he also included information on Queen Maria Kazimiera, the King’s sister Katarzyna Radziwiłłowa née Sobieska (mother of Karol Stanisław), the royal couple’s children (Jakub, Teresa Kunegunda, Aleksander and Konstanty), as well as other members of the court and visitors. He also noted down anecdotes, often loosely connected with medicine. When Kazimierz himself fell seriously ill, he did not seek his patron’s compassion, but assured that despite his illness, he would discharge his duties with the help of third parties, so that Radziwiłł’s interests would not be harmed. His notes are always written in a cold and terse tone, devoid of commentary and empathy. Even those passages which concern him personally are free of emotion.

1999 ◽  
Vol 27 (2) ◽  
pp. 204-205
Author(s):  
Megan Cleary

In recent years, the law in the area of recovered memories in child sexual abuse cases has developed rapidly. See J.K. Murray, “Repression, Memory & Suggestibility: A Call for Limitations on the Admissibility of Repressed Memory Testimony in Abuse Trials,” University of Colorado Law Review, 66 (1995): 477-522, at 479. Three cases have defined the scope of liability to third parties. The cases, decided within six months of each other, all involved lawsuits by third parties against therapists, based on treatment in which the patients recovered memories of sexual abuse. The New Hampshire Supreme Court, in Hungerford v. Jones, 722 A.2d 478 (N.H. 1998), allowed such a claim to survive, while the supreme courts in Iowa, in J.A.H. v. Wadle & Associates, 589 N.W.2d 256 (Iowa 1999), and California, in Eear v. Sills, 82 Cal. Rptr. 281 (1991), rejected lawsuits brought by nonpatients for professional liability.


VASA ◽  
2017 ◽  
Vol 46 (6) ◽  
pp. 452-461 ◽  
Author(s):  
Klaus Amendt ◽  
Ulrich Beschorner ◽  
Matthias Waliszewski ◽  
Martin Sigl ◽  
Ralf Langhoff ◽  
...  

Abstract. Background: The purpose of this observational study is to report the six-month clinical outcomes with a new multiple stent delivery system in patients with femoro-popliteal lesions. Patients and methods: The LOCOMOTIVE study is an observational multicentre study with a primary endpoint target lesion revascularization (TLR) rate at six months. Femoro-popliteal lesions were prepared with uncoated and/or paclitaxel-coated peripheral balloon catheters. When flow limiting dissections, elastic recoil or recoil due to calcification required stenting, up to six short stents per delivery device, each 13 mm in length, were implanted. Sonographic follow-ups and clinical assessments were scheduled at six months. Results: For this first analysis, a total of 75 patients 72.9 ± 9.2 years of age were enrolled. The majority of the 176 individually treated lesions were in the superficial femoral artery (76.2 %, 134/176) whereas the rate of TASC C/D amounted to 51.1 % (90/176). The total lesion length was 14.5 ± 9.0 cm with reference vessel diameters of 5.6 ± 0.7 mm. Overall 47 ± 18 % of lesion lengths could be saved from stenting. At six months, the patency was 90.7 % (68/75) and all-cause TLR rates were 5.3 % (4/75) in the overall cohort. Conclusions: The first clinical experience at six months suggests that the MSDS strategy was safe and effective to treat femoro-popliteal lesions of considerable length (14.5 ± 9.0 cm). Almost half of the lesion length could be saved from stenting while patency was high and TLR rates were acceptably low.


Sign in / Sign up

Export Citation Format

Share Document